HS OBTAIN

Content rating
Everyone
50+
Downloads
Content rating
Everyone
Learn more
Screenshot image
Screenshot image
Screenshot image

About this app

Your app for the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
App for assessing the efficacy and safety of SAR442970 in moderate to severe HS.
Updated on
Mar 4, 2024

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
  • No data shared with third parties
    Learn more about how developers declare sharing
  • No data collected
    Learn more about how developers declare collection
  • Data is encrypted in transit
  • You can request that data be deleted

What’s new

Initial release.